Qualification

2566

Harvard T.H. Chan School of Public Health

United States of America


2562

จุฬาลงกรณ์มหาวิทยาลัย

ประเทศไทย


2560

จุฬาลงกรณ์มหาวิทยาลัย

ประเทศไทย


2558

จุฬาลงกรณ์มหาวิทยาลัย

ประเทศไทย


2552

จุฬาลงกรณ์มหาวิทยาลัย

ประเทศไทย

Selected Publications

Seroprevalence and preventive practices of dengue and chikungunya among school children in Bangkok: Gaps in prevention and vaccination strategies. PLoS Negl Trop Dis. 2026 Mar 16;20(3):e0013026.


Immunogenicity and safety of ‘Comvigen’, a bivalent SARS-CoV-2 vaccine, in comparison to Comirnaty bivalent vaccine in Thailand: a phase 2, non-inferiority randomised trial. Lancet Reg Health Southeast Asia. 2025;40:100650.


Pharmacokinetics and Safety of WHO-Recommended Dosage and Higher Dosage of Levofloxacin for Tuberculosis Treatment in Children: a Pilot Study. Int J Infect Dis. 2022 Jul 13;122:603-608.


Temporal trend of drug-resistant tuberculosis among Thai children during 2006-2021. IJID Reg. 2022 Sep 18;5:79-85.


Short-term immune response after inactivated SARS-CoV-2 (CoronaVac®, Sinovac) and ChAdOx1 nCoV-19 (Vaxzevria®, Oxford-AstraZeneca) vaccinations in health care workers. Asian Pac J Allergy Immunol. 2022 Sep;40(3):269-277.


Dynamics of Neutralizing Antibody and T-Cell Responses to SARS-CoV-2 and Variants of Concern after Primary Immunization with CoronaVac and Booster with BNT162b2 or ChAdOx1 in Health Care Workers. Vaccines (Basel). 2022 Apr 19;10(5):639.


Diagnostic Accuracy of Loop-Mediated Isothermal Amplification (TB-LAMP) for Tuberculosis in Children. J Pediatric Infect Dis Soc. 2021 Oct 13:piab097.


Behavioral problems in perinatally HIV-infected young children with early antiretroviral therapy and HIV-exposed uninfected young children: prevalence and associated factors, AIDS Care. 2020 Apr;32(4):429-437


Low risk of neurodevelopmental impairment among perinatally acquired HIV-infected pre-school children who received early antiretroviral treatment in Thailand. J Int AIDS Soc 2019; 22:e25278


Pharmacokinetics of rilpivirine and 24-week outcomes after switching from efavirenz in virologically-suppressed HIV-1-infected adolescents. Antivir Ther. 2018;23(3)259-265.